recent
year
realtim
pcr
becom
lead
techniqu
nucleic
acid
detect
quantif
assay
potenti
greatli
enhanc
effici
clinic
laboratori
choic
primer
probe
sequenc
critic
accur
diagnosi
clinic
yet
current
primerprob
signatur
design
strategi
limit
signatur
evalu
method
lack
assess
qualiti
signatur
predict
number
true
posit
fals
posit
fals
neg
hit
avail
public
sequenc
data
found
realtim
pcr
signatur
describ
recent
literatur
use
blast
search
base
approach
collect
hit
primerprob
combin
amplifi
realtim
pcr
chemistri
compar
hit
sequenc
ncbi
taxonomi
tree
signatur
design
detect
found
mani
publish
signatur
high
specif
almost
fals
posit
low
sensit
high
fals
neg
rate
high
sensit
need
offer
revis
methodolog
signatur
design
may
design
multipl
signatur
requir
detect
sequenc
strain
use
methodolog
produc
new
signatur
predict
higher
sensit
specif
show
current
method
realtim
pcr
assay
design
unaccept
low
sensit
clinic
applic
addit
new
sequenc
data
becom
avail
old
assay
must
reassess
redesign
standard
protocol
gener
assess
qualiti
assay
therefor
great
valu
realtim
pcr
capac
greatli
improv
clinic
diagnost
improv
assay
design
evalu
method
present
herein
expedit
adopt
techniqu
clinic
lab
realtim
pcr
assay
gain
popular
clinic
tool
detect
quantifi
presenc
viral
bacteri
pathogen
review
compar
tradit
cultur
method
use
identif
realtim
pcr
fast
cost
effect
addit
quantit
sensit
case
greatli
exceed
sensit
convent
test
method
commerci
distribut
kit
avail
pcrbase
pathogen
diagnost
pcr
longer
thought
mere
confirmatori
cultur
howev
realtim
pcr
assay
limit
qualiti
primer
probe
chosen
primer
probe
must
sensit
enough
match
target
organ
yet
specif
enough
exclud
other
common
approach
develop
primerprob
combin
use
commerci
softwar
primerexpress
appli
biosystem
foster
citi
ca
usa
softwar
ask
user
upload
dna
sequenc
file
find
possibl
primerprob
set
meet
assay
criteria
gener
research
provid
input
gene
region
conserv
throughout
taxa
assay
design
detect
softwar
provid
possibl
primerprob
set
research
choos
repres
signatur
singl
nucleotid
polymorph
snp
within
chosen
conserv
region
signatur
consensu
primer
probe
often
chosen
next
blast
search
perform
ensur
primer
hit
target
final
signatur
verifi
vitro
laboratori
strain
design
approach
may
work
accept
well
research
laboratori
clinic
laboratori
call
thorough
analysi
ensur
detect
novel
divers
uncommon
strain
may
appear
exampl
result
spread
foreign
travel
migrat
whole
genom
base
autom
signatur
design
present
great
improv
common
method
howev
addit
better
design
strategi
method
autom
signatur
evalu
need
addit
sequenc
data
becom
avail
necessari
regularli
reassess
predict
efficaci
given
signatur
analysi
must
includ
predict
fals
neg
fals
posit
rate
develop
signatur
consid
avail
public
sequenc
data
analyz
number
realtim
pcr
assay
found
literatur
base
public
sequenc
data
herein
report
well
signatur
perform
offer
revis
approach
pcr
assay
design
use
approach
produc
new
assay
predict
higher
sensit
specif
literatur
comb
recent
publish
articl
report
realtim
pcr
assay
clinic
detect
bacteri
viral
taxa
primer
probe
sequenc
accumul
prefer
taqman
assay
howev
intercal
dye
assay
also
select
paper
report
nucleotid
sequenc
could
easili
copi
onlin
sourc
avoid
total
signatur
paper
analyz
local
oracl
databas
construct
complet
genom
sequenc
data
avail
ncbi
genbank
tigr
embl
img
jgi
baylor
hgsc
use
allviru
allbacteria
databas
find
signatur
match
predict
fals
neg
fals
posit
databas
design
contain
whole
genom
whole
segment
segment
genom
howev
heurist
use
separ
whole
genom
partial
sequenc
failproof
due
inconsist
sequenc
annot
within
public
databas
consequ
mani
sequenc
databas
may
show
fals
neg
actual
section
segment
genom
expect
contain
signatur
manual
sort
sequenc
true
fals
neg
freeli
avail
real
time
pcr
analysi
tool
call
taqsim
use
find
public
sequenc
would
match
primerprob
assay
question
taqsim
use
blast
search
find
sequenc
match
forward
revers
primer
probe
report
hit
primer
probe
must
match
requir
orient
rel
one
anoth
primer
must
suffici
close
proxim
forwardrevers
primer
may
fall
either
plu
minu
strand
long
orient
rel
one
anoth
appropri
may
mismatch
end
either
primer
hit
taqsim
calcul
primer
probe
melt
temperatur
bound
candid
hit
sequenc
account
mismatch
base
reaction
condit
reagent
concentr
hybrid
temperatur
return
sequenc
predict
amplifi
instead
replic
variou
exact
reaction
condit
report
paper
lenient
set
appli
case
essenti
remov
screen
primerprob
vs
candid
hit
tm
set
threshold
instead
check
specif
requir
hit
fewer
mismatch
per
primer
probe
taqsim
predict
sequenc
hit
compar
sequenc
list
given
set
ncbi
taxonomi
tree
node
instanc
signatur
report
detect
hepat
b
set
taqsim
hit
would
compar
set
sequenc
node
correspond
hepat
b
viru
sequenc
set
consid
true
posit
sequenc
taqsim
output
miss
chosen
taxonomi
node
consid
fals
posit
sequenc
taxonomi
tree
miss
taqsim
output
consid
fals
neg
test
statist
specif
sensit
power
calcul
paper
defin
sensit
specif
follow
primari
research
articl
read
care
determin
author
design
primersprob
detect
ncbi
taxonomi
node
chosen
repres
target
organ
trivial
task
sinc
mani
articl
lack
clariti
taxa
specif
assay
detect
instanc
cytomegaloviru
assay
detect
sequenc
cytomegaloviru
genu
taxonomi
node
rather
sequenc
human
herpesviru
speci
taxonomi
node
none
articl
specifi
taxonomi
node
signatur
perl
script
use
help
compar
blast
hit
taxonomi
node
sequenc
count
fals
neg
fals
posit
true
posit
sequenc
match
howev
sequenc
requir
hand
sort
due
wide
array
sequenc
type
annot
often
repres
segment
genom
case
mani
wouldb
fals
neg
sequenc
simpli
repres
differ
segment
signatur
land
manual
tabul
true
neg
may
also
repres
plasmid
situat
care
review
genbank
entri
sometim
primari
articl
cite
genbank
necessari
determin
sequenc
interest
truli
fals
neg
although
attempt
includ
complet
genom
sequenc
databas
inconsist
annot
sequenc
data
partial
sequenc
nevertheless
make
databas
partial
cd
document
contain
target
gene
signatur
suppos
land
count
fals
neg
partial
cd
document
contain
target
gene
elimin
fals
neg
pool
possibl
signatur
could
land
unsequenc
section
target
gene
databas
also
contain
glu
fragment
repres
draft
genom
glu
togeth
hundr
n
simpl
way
keep
separ
contig
associ
part
genom
report
fals
neg
draft
genom
possibl
signatur
could
land
gap
contig
finish
sequenc
could
result
reclassif
true
posit
tabl
summar
analysi
variou
dna
signatur
detail
true
posit
fals
posit
fals
neg
sequenc
avail
author
note
result
silico
result
laboratori
test
perform
verif
state
organ
detect
mean
predict
base
sequenc
data
note
interest
concern
data
tabl
describ
two
human
corona
viru
strain
frequent
caus
common
cold
taqman
assay
predict
perform
perfectli
assay
turn
number
fals
posit
anim
corona
virus
coxsacki
viru
assay
perform
well
coxsacki
assay
hit
mani
human
coxsacki
echo
entero
virus
four
fals
neg
marburg
viru
assay
lake
victoria
varieti
fals
neg
associ
yellow
fever
signatur
includ
trinidad
french
neurotrop
french
viscerotrop
vaccin
strain
filovirida
ebolamarburg
assay
detect
ebola
virus
staphylococcu
aureu
enterobacteriacea
assay
low
sensit
escherichia
coli
assay
hit
shigella
vibrio
sequenc
mani
signatur
high
sensit
combin
sever
multiplex
assay
would
probabl
improv
sensit
signatur
design
use
minim
set
cluster
approach
individu
signatur
decent
sensit
combin
sever
signatur
one
assay
advoc
public
greatli
improv
sensit
signatur
hepat
current
undergo
laboratori
screen
fda
perform
well
g
hartman
person
commun
sever
report
signatur
produc
predict
hit
includ
assay
sever
flavivirus
rrna
assay
sever
bacteria
examin
blast
output
show
case
either
primer
intern
oligo
probe
blast
hit
target
mani
mismatch
per
primer
probe
sequenc
threshold
specifi
anal
three
taqman
signatur
three
intercal
dye
type
assay
bold
yse
mismatch
end
primer
rel
target
possibl
sequenc
sampl
use
laboratori
differ
avail
genom
data
pcr
reaction
condit
perform
low
stringenc
eg
low
anneal
temperatur
high
salt
concentr
assay
could
fact
work
laboratori
howev
accord
genom
data
avail
better
match
primer
probe
target
possibl
usual
desir
high
sensit
detect
target
number
organ
current
publish
signatur
predict
perform
poorli
well
addit
signatur
may
desir
even
though
publish
signatur
may
perform
well
gener
new
signatur
use
minim
set
cluster
msc
accord
method
previous
describ
msc
begin
remov
nonuniqu
region
consider
primer
probe
target
sequenc
rel
databas
nontarget
bacteri
viral
sequenc
remain
uniqu
region
target
sequenc
mine
mani
candid
signatur
without
regard
conserv
among
target
yet
satisfi
user
specif
primer
probe
length
gc
avoid
long
homopolym
run
amplicon
length
candid
signatur
compar
target
cluster
subset
target
predict
detect
signatur
within
given
cluster
equival
predict
detect
subset
target
cluster
reduc
redund
size
problem
find
small
set
signatur
detect
target
nevertheless
find
optim
solut
fewest
cluster
detect
target
np
complet
problem
larg
data
set
use
greedi
algorithm
find
small
number
cluster
togeth
pick
target
supplementari
tabl
often
provid
one
altern
signatur
detect
given
equival
group
genom
serv
backup
signatur
perform
poorli
laboratori
test
signatur
may
mismatch
intend
target
although
mismatch
predict
reduc
primerprob
hybrid
target
typic
taqman
reaction
condit
none
comput
predict
signatur
screen
laboratori
beyond
scope
paper
year
target
pseudomona
aeruginosa
escherichia
coli
neisseria
meningitidi
expect
found
fals
neg
much
common
fals
posit
though
signatur
gener
base
conserv
gene
region
often
fail
take
account
variat
within
target
set
organ
may
signatur
develop
use
sequenc
data
hand
strain
rather
thorough
studi
strain
publicli
avail
fals
neg
may
also
repres
sequenc
becom
avail
sinc
public
given
signatur
sinc
new
sequenc
data
made
avail
ever
increas
rate
great
benefit
reevalu
clinic
use
dna
signatur
regularli
new
sequenc
data
lead
fals
neg
predict
signatur
one
two
explan
given
new
sequenc
either
repres
recent
recogn
variat
around
sinc
time
signatur
publish
new
variat
result
mutat
natur
select
either
case
improv
addit
signatur
design
high
fals
posit
fals
neg
rate
necessarili
indic
bad
dna
assay
qualiti
assay
must
consid
light
milieu
test
take
place
clinic
laboratori
signatur
high
sensit
perhap
low
specif
may
prefer
test
lower
sensit
case
put
pathogen
requir
immedi
treatment
may
spread
quickli
case
antibiot
resist
bacteria
probabl
fall
categori
hand
nation
basi
biowatch
program
insist
zero
fals
posit
avoid
public
disturb
due
fals
alarm
still
aim
zero
fals
neg
one
must
also
consid
type
fals
neg
fals
posit
result
determin
relev
instanc
articl
assay
human
corona
viru
match
clinic
lab
africa
hand
echoviru
sequenc
coxsacki
assay
detect
could
produc
mislead
result
clinic
lab
fals
neg
fals
posit
rate
present
studi
may
vari
substanti
seen
empir
strain
avail
laboratori
may
differ
significantli
sequenc
data
avail
empir
protocol
less
stringent
sequencebas
requir
impos
allow
mismatch
per
primer
probe
detect
believ
target
sequenc
becom
avail
predict
fals
neg
rate
tend
increas
given
publish
signatur
result
better
sampl
divers
result
failur
detect
newli
evolv
variant
estim
minimum
genom
need
order
comput
design
taqman
pcr
signatur
like
detect
strain
isol
chosen
sequenc
select
span
gradient
geograph
phenotyp
tempor
variat
even
genom
need
particularli
divers
organ
thu
older
signatur
may
perform
well
newli
develop
signatur
uptod
sequenc
data
futur
studi
interest
would
longitudin
look
rate
continu
chang
time
addit
sequenc
becom
avail
studi
could
perform
retrospect
sinc
sequenc
submiss
date
easili
obtain
public
databas
also
hypothes
wider
intend
scope
signatur
lower
sensit
would
tend
point
illustr
loos
data
tabl
twentysix
signatur
less
publicli
avail
target
sequenc
sensit
ie
zero
fals
neg
signatur
target
averag
sensit
howev
approach
consid
scope
context
sequenc
data
avail
tri
demonstr
relationship
specif
scope
fundament
level
group
signatur
taxonom
level
target
shown
figur
howev
result
mislead
virolog
taxonom
level
good
indic
nucleotid
divers
instanc
divers
influenza
speci
entir
filovirida
famili
consist
two
known
genera
ebolalik
virus
marburg
virus
better
approach
might
calcul
nucleotid
divers
function
phylogenet
branch
length
share
kmer
cluster
within
target
taxonomi
node
final
averag
sensit
microb
genom
type
shown
tabl
note
ssrnart
categori
includ
chart
demonstr
creat
signatur
high
sensit
becom
difficult
target
organ
high
mutat
rate
current
realtim
pcr
assay
design
approach
produc
signatur
sensit
gener
low
clinic
use
suggest
rigor
approach
involv
fals
posit
fals
neg
analysi
standard
initi
assess
signatur
qualiti
made
signatur
must
also
regularli
reassess
sequenc
data
becom
avail
target
wide
nucleotid
divers
becom
necessari
develop
set
signatur
suggest
minim
set
cluster
approach
may
also
includ
signatur
degenerateinosin
base
newrealtimepcrsigatur
fifti
seven
taqman
pcr
primerprob
combin
predict
higher
sensitivityspecif
current
publish
assay
click
file
http
sensit
taxonomi
level
figur
sensit
taxonomi
level
color
diamond
repres
realtim
pcr
assay
examin
paper
black
bar
indic
mean
grey
bar
indic
median
top
bottom
box
indic
percentil
grey
line
whisker
end
denot
min
max
valu
wide
rang
sensit
demonstr
inconsist
genet
divers
given
taxonomi
level
inconsist
signatur
design
approach
